Clinical Trials
2 trialsNCT00934076 2015-05-08
Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer
University of Alabama at Birmingham
Phase 1 Withdrawn
NCT00544960 2010-08-27
A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer
Ascenta Therapeutics
Phase 2 Completed